Abstract
Not available.
| Original language | English |
|---|---|
| Pages (from-to) | 1-5 |
| Number of pages | 5 |
| Journal | Expert Opinion on Drug Delivery |
| Volume | 14 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2 Jan 2017 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer nanomedicines
- Clinical translation
- Clinical trials
- Combination treatment
- Drug delivery
- Drug targeting
- EPR effect
- Triggered release
Fingerprint
Dive into the research topics of 'Cancer nanomedicines: oversold or underappreciated?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver